HFS
HARP

Hantz Financial Services’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Hantz Financial Services’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed – – 1255
2023
Q3 		$0 Hold
2
– – ﹤0.01% 1211
2023
Q2 		$0 Hold
2
– – ﹤0.01% 1205
2023
Q1 		$0 Buy
+2
New +$17 ﹤0.01% 1228

Other funds holding HARP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hantz Financial Services's HARP Position: Q4 2023 in Review

Hantz Financial Services sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2023, closing a stake of 2 shares.

Hantz Financial Services first reported a position in HARP in Q1 2023 and held it in 3 quarters. The position peaked at $0 in Q3 2023. 41 funds tracked by Wall St. Rank hold HARP as of Q4 2023.

  • Hantz Financial Services reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Hantz Financial Services sold 2 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2023.
  • Hantz Financial Services first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Hantz Financial Services's Harpoon Therapeutics, Inc. Common Stock position peaked at $0 in Q3 2023.
  • 41 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Hantz Financial Services's 13F filing for Q4 2023, filed 14 Feb 2024.